BIG PHARMA’S SEEDY SECRET HISTORY!
By Hans Ruesch
In the 30’s, Morris A. Bealle, a former city editor of the old Washington Times and Herald, was running a county seat newspaper, in which the local power company bought a large advertisement every week. This account took quite a lot of worry off Bealle’s shoulders when the bills came due.
But according to Bealle’s own story, one day the paper took up the cudgels for some of its readers that were being given poor service from the power company, and Morris Bealle received the dressing down of his life from the advertising agency which handled the power company’s account. They told him that any more such “stepping out of line” would result in the immediate cancellation not only of the advertising contract, but also of the gas company and the telephone company.
That’s when Bealle’s eyes were opened to the meaning of a “free press”, and he decided to get out of the newspaper business. He could afford to do that because he belonged to the landed gentry of Maryland, but not all newspaper editors are that lucky.
Bealle used his professional experience to do some deep digging into the freedom-of-the-press situation and came up with two shattering exposés — “The Drug Story”, and “The House of Rockefeller.” The fact that in spite of his familiarity with the editorial world and many important personal contacts he couldn’t get his revelations into print until he founded his own company, The Columbia Publishing House, Washington D.C., in 1949, was just a prime example of the silent but adamant censorship in force in “the Land of the Free and the Home of the Brave”. Although The Drug Story is one of the most important books on health and politics ever to appear in the USA, it has never been admitted to a major bookstore nor reviewed by any establishment paper, and was sold exclusively by mail. Nevertheless, when we first got to read it, in the 1970s, it was already in its 33rd printing, under a different label – Biworld Publishers, Orem, Utah.
As Bealle pointed out, a business which makes 6% on its invested capital is considered a sound money maker. Sterling Drug, Inc., the main cog and largest holding company in the Rockefeller Drug Empire and its 68 subsidiaries, showed operating profits in 1961 of $23,463,719 after taxes, on net assets of $43,108,106 – a 54% profit. Squibb, another Rockefeller-controlled company, in 1945 made not 6% but 576% on the actual value of its property.
That was during the luscious war years when the Army Surgeon General’s Office and the Navy Bureau of Medicine and Surgery were not only acting as promoters for the Drug Trust, but were actually forcing drug trust poisons into the blood streams of American soldiers, sailors and marines, to the tune of over 200 million ‘shots’. Is it any wonder, asked Bealle, that the Rockefellers, and their stooges in the Food and Drug Administration, the U.S. Public Health Service, the Federal Trade Commission, the Better Business Bureau, the Army Medical Corps, the Navy Bureau of Medicine, and thousands of health officers all over the country, should combine to put out of business all forms of therapy that discourage the use of drugs.
“The last annual report of the Rockefeller Foundation”, reported Bealle, “itemizes the gifts it has made to colleges and public agencies in the past 44 years, and they total somewhat over half a billion dollars. These colleges, of course, teach their students all the drug lore the Rockefeller pharmaceutical houses want taught. Otherwise there would be no more gifts, just as there are no gifts to any of the 30 odd colleges in the United States that don’ t use therapies based on drugs.
“Harvard, with its well-publicized medical school, has received $8,764,433 of Rockefeller’s Drug Trust money, Yale got $7,927,800, Johns Hopkins $10,418,531, Washington University in St. Louis $2,842,132, New York’s Columbia University $5,424,371, Cornell University $1,709,072, etc., etc.”